GSL

AIMT failed breakout after first IPO base pattern.

NASDAQ:AIMT   AIMMUNE THERAPEUTICS INC
75 0 0
AIMT formed a classic cup-with-handle IPO base, and eclipsed its buy point at $26.08 on a huge spike in volume on September 30. The breakout failed the very next day. Still basing. A downside break of $18.47 (the Aug 24 low) would set up a larger double-bottom base.
United States
United Kingdom
India
Deutschland
España
France
Italia
Polska
Brasil
Россия
Türkiye
Indonesia
Malaysia
日本
한국
简体
繁體
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing Priority Support Ideas Published Followers Following Private Messages Chat Sign Out